| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Okuyama-Dobashi K et al. | Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide. | 2015 | Sci Rep | pmid:26592202 |
| Denicolaï E et al. | Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo. | 2014 | Oncotarget | pmid:25400117 |
| El-Seedi HR et al. | The traditional medical uses and cytotoxic activities of sixty-one Egyptian plants: discovery of an active cardiac glycoside from Urginea maritima. | 2013 | J Ethnopharmacol | pmid:23228916 |
| Winnicka K et al. | Inhibition of DNA topoisomerases I and II by G3 PAMAM-NH2 dendrimer-modified digoxin and proscillaridin A conjugates in a cell free system. | 2010 Nov-Dec | Acta Pol Pharm | pmid:21229879 |
| Winnicka K et al. | Synthesis and cytotoxic activity of G3 PAMAM-NH(2) dendrimer-modified digoxin and proscillaridin A conjugates in breast cancer cells. | 2010 Mar-Apr | Pharmacol Rep | pmid:20508299 |
| Winnicka K et al. | Dual effects of ouabain, digoxin and proscillaridin A on the regulation of apoptosis in human fibroblasts. | 2010 | Nat. Prod. Res. | pmid:20140806 |
| Felth J et al. | Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs. | 2009 | J. Nat. Prod. | pmid:19894733 |
| Winnicka K et al. | Antiproliferative activity of derivatives of ouabain, digoxin and proscillaridin A in human MCF-7 and MDA-MB-231 breast cancer cells. | 2008 | Biol. Pharm. Bull. | pmid:18520043 |
| Winnicka K et al. | Apoptosis-mediated cytotoxicity of ouabain, digoxin and proscillaridin A in the estrogen independent MDA-MB-231 breast cancer cells. | 2007 | Arch. Pharm. Res. | pmid:18038900 |
| Bielawski K et al. | Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A. | 2006 | Biol. Pharm. Bull. | pmid:16819197 |
| Terness P et al. | Exquisitely small amounts of nonglucocorticoid natural steroids suppress the human allogeneic T-cell response. | 2001 Feb-Mar | Transplant. Proc. | pmid:11266951 |
| Kodama-Takahashi K et al. | [An elderly case of idiopathic dilatation of the right atrium in which right-sided heart failure was exacerbated by drug-induced bradyarrhythmia]. | 2001 | Nihon Ronen Igakkai Zasshi | pmid:11523170 |
| Terness P et al. | The T-cell suppressive effect of bufadienolides: structural requirements for their immunoregulatory activity. | 2001 | Int. Immunopharmacol. | pmid:11367509 |
| Schneider R et al. | Proscillaridin A immunoreactivity: its purification, transport in blood by a specific binding protein and its correlation with blood pressure. | 1998 Jul-Aug | Clin. Exp. Hypertens. | pmid:9682915 |
| Li S et al. | Bovine adrenals and hypothalamus are a major source of proscillaridin A- and ouabain-immunoreactivities. | 1998 | Life Sci. | pmid:9515560 |
| Li SQ et al. | Proscillaridin A immunoreactivity: a new endogenous cardiac glycoside? | 1997 | Ann. N. Y. Acad. Sci. | pmid:9405880 |
| Nguyen AT and Doris PA | Role of endogenous cardiac glycosides in the spontaneously hypertensive rat--antagonism by active immunization. | 1996 | Am. J. Hypertens. | pmid:8834711 |
| Sich B et al. | Pulse pressure correlates in humans with a proscillaridin A immunoreactive compound. | 1996 | Hypertension | pmid:8621199 |
| Tanase T et al. | Cardiac glycoside-induced elevation of intracellular Na+ ion concentration in human erythrocytes studied by 23Na NMR spectroscopy: relationship between inotropy speed and elevation rate of intracellular Na+ ion concentration. | 1993 | Biol. Pharm. Bull. | pmid:8358396 |
| Okamoto M and Tsukahara T | [Preparation of phenylpropylsilica and its application to high performance liquid chromatographic analysis of proscillaridin]. | 1993 | Yakugaku Zasshi | pmid:8387581 |
| Tanase T et al. | Studies on cardiac ingredients of plants. IX. Chemical transformation of proscillaridin by utilizing its 1,4-cycloadducts as key compounds and biological activities of their derivatives. | 1992 | Chem. Pharm. Bull. | pmid:1318790 |
| Tanase T et al. | [Studies on cardiac ingredients of plants. X. Preparation of nitrates of tetrahydroproscillaridin and their pharmacological activities]. | 1992 | Yakugaku Zasshi | pmid:1336548 |
| Murakami N et al. | [Studies on cardiac ingredients of plants. VIII. Preparation of nitrates of proscillaridin and their pharmacological activities]. | 1991 | Yakugaku Zasshi | pmid:1665512 |
| Murakami N et al. | Studies on cardiac ingredients of plants. VII: Chemical transformation of proscillaridin by means of the Diels-Alder reaction and biological activities of its derivatives. | 1991 | Chem. Pharm. Bull. | pmid:1839142 |
| Sabouraud A et al. | Specific anti-digoxin Fab fragments: an available antidote for proscillaridin and scilliroside poisoning? | 1990 | Hum Exp Toxicol | pmid:2375888 |
| Mori J et al. | Studies on cardiac ingredients of plants. V. Chemical transformation of proscillaridin and biological activities of derivatives. | 1988 | Chem. Pharm. Bull. | pmid:3378308 |
| Bonelli J et al. | Hemodynamic effect of methylepoxyproscillaridin (P35) in patients with congestive myocardiopathy. | 1988 | Int J Clin Pharmacol Ther Toxicol | pmid:3410600 |
| Bonelli J et al. | The bioavailability of methylepoxyproscillaridin (P35): a new semisynthetic cardiac glycoside. | 1988 | Int J Clin Pharmacol Ther Toxicol | pmid:3410606 |
| Mori J et al. | Studies on cardiac ingredients of plants. III. Structural confirmation and biological activity of reduced proscillaridins. | 1987 | Chem. Pharm. Bull. | pmid:2822265 |
| Sakakibara J et al. | [Studies on cardiac ingredients of plants (IV). Effect of reduced proscillaridins on guinea-pig hearts]. | 1987 | Nippon Yakurigaku Zasshi | pmid:3679019 |
| Kojima K et al. | Determination of proscillaridin in plasma by radioimmunoassay. | 1986 | J. Pharmacobio-dyn. | pmid:3783410 |
| Röder E and Lütz J | [Potential radiopharmaceutical for adrenal gland scintigraphy. 1. Radioiodination of tyramine derivatives of some derivatives of digitoxigenin and scillarenin]. | 1985 | Arch. Pharm. (Weinheim) | pmid:4084030 |
| Franco PD et al. | [Use of a cardiotonic agent in the ventricular pre-excitation syndrome. Report of a case]. | 1985 | Arq. Bras. Cardiol. | pmid:4096667 |
| Alken RG and Belz GG | A comparative dose-effect study with cardiac glycosides assessing cardiac and extracardiac responses in normal subjects. | 1984 Jul-Aug | J. Cardiovasc. Pharmacol. | pmid:6206318 |
| Burkert K and Beckmann H | [Plasma concentration and elimination behavior of the cardiac glycoside meproscillarin in patients with liver cirrhosis]. | 1983 | Z Gastroenterol | pmid:6845784 |
| Lüllmann H et al. | Electrophysiological studies of some semisynthetic cardiac glycoside derivatives in isolated papillary muscle of the guinea-pig. | 1983 | Br. J. Pharmacol. | pmid:6652355 |
| Brock N et al. | Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna). | 1982 | Eur J Cancer Clin Oncol | pmid:6819957 |
| Tytman B | [Evaluation of the practical use of mathematical methods and computer technics for the control of treatment with selected digitalis glycosides]. | 1981 | Pol Tyg Lek | pmid:7335534 |
| Ferrer M et al. | [Densitometric determination of proscillaridin A, scillaren A and scilliroside]. | 1980 | Farmaco Prat | pmid:7449933 |
| Belz GG and Aust PE | [Threshold of action of meproscillarin following intravenous administration]. | 1980 | Med Klin | pmid:7001203 |
| Lindner E et al. | [14,15-beta-oxido analog of proscillaridin (HOE 040). A new cardiac glycoside with low arrhythmic activity and greater absorption ratio]. | 1979 | Arzneimittelforschung | pmid:109100 |
| Beckmann H et al. | [Meproscillarin in patients with renal failure and concomitant heart failure (author's transl)]. | 1979 | Med Klin | pmid:522817 |
| Tytman B | [Construction of tables facilitating daily control of treatment with proscillaridin A]. | 1979 | Pol Tyg Lek | pmid:575563 |
| Bergdahl B | Disposition rate of proscillaridin A in man after multiple oral doses. | 1979 | Arzneimittelforschung | pmid:582147 |
| Regal DS and Waginger H | [Effect of proscillaridin on specific adenosine triphosphatases in heart muscle of rats. Electron optical demonstration and significance for calcium metabolism]. | 1978 | Zentralbl Veterinarmed A | pmid:212903 |
| Regal DS | [Effect of proscillaridin on adenosine triphosphatase in kidney tissue in the rat. Electron microscopy demonstration and significance for calcium metabolism]. | 1978 | Zentralbl Veterinarmed A | pmid:153691 |
| Kubinyi H | [Meproscillarin, a new semisynthetic cardiac glycoside/chemistry and physical properties (author's transl)]. | 1978 | Arzneimittelforschung | pmid:580577 |
| Friedrich L et al. | [Studies on extracardiac effects of the cardiac glycoside meproscillarin in animal experiments (author's transl)]. | 1978 | Arzneimittelforschung | pmid:580579 |
| Andersson KE et al. | Biliary excretion and enterochepatic recycling of proscillaridin A after oral adminstration to man. | 1977 | Eur. J. Clin. Pharmacol. | pmid:862647 |
| Andersson KE et al. | Proscillaridin activity in portal and peripheral venous blood after oral administration to man. | 1977 | Eur. J. Clin. Pharmacol. | pmid:862648 |
| Bergdahl B and Andersson KE | Stability in vitro of methylproscillaridin. | 1977 | Eur. J. Clin. Pharmacol. | pmid:16755 |
| Stauch M et al. | [Effect of proscillaridin-4'-methylether on pressure rise velocity in the left ventricle of patients with coronary heart disease (author's transl)]. | 1977 | Klin. Wochenschr. | pmid:330937 |
| Stefan G | [Echocardiography during the therapy of cardiovascular diseases]. | 1977 | MMW Munch Med Wochenschr | pmid:401936 |
| Wójcicki J and Stanosz S | [Comparative studies of action in cats of intraintestinally administered digoxin, proscillardin and K- strophantoside]. | 1977 | Acta Pol Pharm | pmid:930618 |
| Garcia Casado P et al. | Proscillaridin A yield from squill bulbs. | 1977 | Pharm Acta Helv | pmid:565519 |
| Andersson KE et al. | On the absorption of proscillaridin A after single oral doses to normal and achlorhydric subjects. | 1977 | Acta Pharmacol Toxicol (Copenh) | pmid:576356 |
| Andersson KE et al. | Activities of proscillaridin A in thoracic duct lymph after single oral doses in man. | 1977 | Acta Pharmacol Toxicol (Copenh) | pmid:576557 |
| Neugebauer G | [Influence of high intravenous doses of D-penicillamine on toxic actions of cardiac glycosides in the guinea pig. Short communication (author's transl)]. | 1977 | Arzneimittelforschung | pmid:580003 |
| Belz GG et al. | Pharmacokinetics and pharmacodynamics of methyl proscillaridin in healthy man. | 1976 | Eur. J. Clin. Pharmacol. | pmid:786669 |
| Einig H | [Investigations on the Stability of Proscillaridine, Proscillaridine-3'-methylether and Proscillaridine-4'-methylether in Artificial Gastric and Intestinal Fluids (author's transl)]. | 1976 | Arzneimittelforschung | pmid:12764 |
| Belz GG et al. | Plasma concentrations during repeated intravenous and oral methyl-proscillaridin application in man. | 1976 | Arzneimittelforschung | pmid:947212 |
| Krämer KD and Hochrein H | [Enteral availability and therapeutic activity of proscillaridin-4'-methyl ether (author's transl)]. | 1976 | Arzneimittelforschung | pmid:989015 |
| Bellardo G and Pichierri U | [Trial of a combination of proscillaridin A, thioridazine and Cori ester in the ambulatory treatment of some cardiopathies, especially senile types]. | 1976 | Minerva Med. | pmid:967364 |
| Stefan G | [Echocardiographic evaluation of left ventricular function during therapy with cardiovascularly effective drugs]. | 1976 | Z Kardiol | pmid:969820 |
| Krämer KD and Hochrein H | [Enteral availability and suggested dosages for methyl proscillaridin in decompensated heart patients]. | 1975 | Verh Dtsch Ges Inn Med | pmid:1227053 |
| Andersson KE et al. | On the pharmacokinetics of proscillaridin A in man. | 1975 | Eur. J. Clin. Pharmacol. | pmid:1233243 |
| Rietbrock N and Staud R | Metabolism and excretion of methylproscillaridin by man. | 1975 | Eur. J. Clin. Pharmacol. | pmid:1233244 |
| Staud R et al. | Excretion of methylproscillaridin in patients with a biliary fistula. | 1975 | Eur. J. Clin. Pharmacol. | pmid:1233271 |
| Andersson KE et al. | In vitro stability of proscillaridin A. | 1975 | Eur. J. Clin. Pharmacol. | pmid:9294 |
| Zalar S et al. | [Relationship between binding to the myocardium and effects of proscillaridin on isolated perfused heart of the guinea pig]. | 1975 | Boll Chim Farm | pmid:1131317 |
| Nishida H et al. | [Effect of proscillaridin on active cation transport across human red cell membrane (author's transl)]. | 1974 | Hokkaido Igaku Zasshi | pmid:4477138 |
| Nishida H | [Studies on direct effects of proscillaridin A on the electrolyte excretion and transport ATPase in dog kidneys (author's transl)]. | 1974 | Hokkaido Igaku Zasshi | pmid:4281758 |
| pmid: |
Scillarenin 3-o-rhamnoside
Scillarenin 3-o-rhamnoside is a lipid of Sterol Lipids (ST) class.
Cross Reference
